Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Cardiovascular >> Angiogenesis >> Growth Factors >> VEGF >> VEGF
Anti-VEGF 165B antibody [MRVL56/1]
See all VEGF 165B products (2) ...
Mouse monoclonal [MRVL56/1] to VEGF 165B
This antibody has been used to detect VEGF 165b in Western blotting using recombinant protein and protein samples extracted from cells, it specifically detects VEGF 165b but not VEGF 165.
WB, IHC-P, IF, ELISAmore details
Reacts with
Rat, Human
Synthetic peptide (Human) corresponding to the 9 amino acid C-terminal sequence of VEGF165b, coupled to KLH.
This antibody gave a positive signal in VEGF 165b HNCO2 whole cell lysate.
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 0.02% Sodium Azide
Constituents: PBS, pH 7.5
Concentration information loading...
IgG fraction
Monoclonal
MRVL56/1
IgG1
Cancer >> Oncoproteins/suppressors >> Oncoproteins >> Growth factor receptors
Cancer >> Invasion/microenvironment >> Angiogenesis >> Angiogenic inhibitory factors
Cancer >> Growth factors >> VEGF
Signal Transduction >> Growth Factors/Hormones >> VEGF
Cardiovascular >> Angiogenesis >> Growth Factors >> VEGF >> VEGF
Our Abpromise guarantee covers the use of ab14994 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 1 µg/mlDetects a band of approximately 23 kDa (predicted molecular weight: 22 kDa).
IHC-P: Use a concentration of 2 µg/mlPerform heat mediated antigen retrieval before commencing with IHC staining protocol.
IF: Use at an assay dependent dilution.
ELISA: Use at an assay dependent dilution.
Angiogenesis, required for all tumor growth, is stimulated by the expression of vascular endothelial growth factor (VEGF). VEGF is up-regulated in all known solid tumors but also in atherosclerosis, diabetic retinopathy, arthritis, and many other conditions. Conventional VEGF isoforms have been universally described as proangiogenic cytokines. VEGF 165b, an endogenous splice variant, is expressed as protein in normal cells and tissues and is circulating in human plasma. VEGF 165b binds VEGF receptor 2 with the same affinity as VEGF 165 but does not activate it or stimulate downstream signaling pathways. Moreover, it prevents VEGF 165-mediated VEGF receptor 2 phosphorylation and signaling in cultured cells. VEGF 165b is not angiogenic and it inhibits VEGF 165-mediated angiogenesis in rabbit cornea and rat mesentery.
Secreted
Western blot - VEGF 165B antibody [MRVL56/1] (ab14994)
![Western blot - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/Images/14/ab14994/ab14994_1.jpg)
Lanes 1 - 2 : clone MRVL56/1 at 1 µg/ml
Lanes 3 - 4 : pan VEGF antibody
Lane 1 : VEGF165B recombinant
Lane 2 : VEGF165 recombinant
Lane 3 : VEGF165B recombinant
Lane 4 : VEGF165 recombinant
Secondary
anti-mouse IgG
developed using the ECL technique
Predicted band size : 22 kDa
Immunohistochemistry - VEGF 165B antibody [MRVL56/1] (ab14994)
![Immunohistochemistry - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/Images/14/ab14994/ab14994_2.jpg)
Top panel: clone MRVL56/1 used on human renal glomerus at 2ug/ml.
Bottom panel: control IgG primary used on human renal glomerus at 2ug/ml.
ELISA - VEGF 165B antibody [MRVL56/1] (ab14994)
![ELISA - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/Images/14/ab14994/ab14994_3.gif)
ELISA on recombinant VEGF 165B.
Blue - clone MRVL56/1
Red - Pan VEGF antibody
Western blot - VEGF 165B antibody [MRVL56/1] (ab14994)
![Western blot - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/images/14/ab14994/VEGF-165B-Primary-antibodies-ab14994-2.jpg)
Anti-VEGF 165B antibody [MRVL56/1] (ab14994) at 5 µg/ml + VEGF 165b HNCO2 at 10 µl
Secondary
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Performed under reducing conditions.
Predicted band size : 22 kDa
Observed band size : 23 kDa (why is the actual band size different from the predicted?)
Exposure time : 16 minutes
This product has been referenced in:
See all 3 publications for this product
Publishing research using ab14994? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Western blot - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/Images/14/ab14994/ab14994_1.jpg)
Lanes 1 - 2 : clone MRVL56/1 at 1 µg/ml
Lanes 3 - 4 : pan VEGF antibody
Lane 1 : VEGF165B recombinant
Lane 2 : VEGF165 recombinant
Lane 3 : VEGF165B recombinant
Lane 4 : VEGF165 recombinant
Secondary
anti-mouse IgG
developed using the ECL technique
Predicted band size : 22 kDa
![Immunohistochemistry - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/Images/14/ab14994/ab14994_2.jpg)
Top panel: clone MRVL56/1 used on human renal glomerus at 2ug/ml.
Bottom panel: control IgG primary used on human renal glomerus at 2ug/ml.
![ELISA - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/Images/14/ab14994/ab14994_3.gif)
ELISA on recombinant VEGF 165B.
Blue - clone MRVL56/1
Red - Pan VEGF antibody
![Western blot - VEGF 165B antibody [MRVL56/1] (ab14994)](/ps/datasheet/images/14/ab14994/VEGF-165B-Primary-antibodies-ab14994-2.jpg)
Anti-VEGF 165B antibody [MRVL56/1] (ab14994) at 5 µg/ml + VEGF 165b HNCO2 at 10 µl
Secondary
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Performed under reducing conditions.
Predicted band size : 22 kDa
Observed band size : 23 kDa (why is the actual band size different from the predicted?)
Exposure time : 16 minutes
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
